PL353012A1 - Środek leczniczy o działaniu chroniącym przeciwkotoksycznym substancjom utleniającym, zwłaszcza przeciwko substancjom szkodliwym dla serca - Google Patents

Środek leczniczy o działaniu chroniącym przeciwkotoksycznym substancjom utleniającym, zwłaszcza przeciwko substancjom szkodliwym dla serca

Info

Publication number
PL353012A1
PL353012A1 PL00353012A PL35301200A PL353012A1 PL 353012 A1 PL353012 A1 PL 353012A1 PL 00353012 A PL00353012 A PL 00353012A PL 35301200 A PL35301200 A PL 35301200A PL 353012 A1 PL353012 A1 PL 353012A1
Authority
PL
Poland
Prior art keywords
substances
medicament
protective effect
cardiotoxic
toxic substances
Prior art date
Application number
PL00353012A
Other languages
English (en)
Other versions
PL198723B1 (pl
Inventor
Zsuzsanna Rozsa
Julius Gy. Papp
Dirk Thormahlen
Harald Waldeck
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of PL353012A1 publication Critical patent/PL353012A1/pl
Publication of PL198723B1 publication Critical patent/PL198723B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL353012A 1999-07-13 2000-07-10 Zastosowanie pochodnych kwasu benzazepino-N-octowego oraz wytwory zawierające cytostatyk i pochodne kwasu benzazepino-N-octowego PL198723B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19932555A DE19932555A1 (de) 1999-07-13 1999-07-13 Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
PCT/EP2000/006525 WO2001003699A1 (de) 1999-07-13 2000-07-10 Arzneimittel mit protektiver wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische substanzen

Publications (2)

Publication Number Publication Date
PL353012A1 true PL353012A1 (pl) 2003-10-06
PL198723B1 PL198723B1 (pl) 2008-07-31

Family

ID=7914519

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353012A PL198723B1 (pl) 1999-07-13 2000-07-10 Zastosowanie pochodnych kwasu benzazepino-N-octowego oraz wytwory zawierające cytostatyk i pochodne kwasu benzazepino-N-octowego

Country Status (28)

Country Link
US (1) US6906059B2 (pl)
EP (1) EP1200095B1 (pl)
JP (1) JP4824235B2 (pl)
KR (1) KR100738940B1 (pl)
CN (1) CN1267099C (pl)
AR (1) AR024476A1 (pl)
AT (1) ATE306926T1 (pl)
AU (1) AU782733B2 (pl)
BR (1) BR0012442A (pl)
CA (1) CA2377904C (pl)
CZ (1) CZ299070B6 (pl)
DE (2) DE19932555A1 (pl)
DK (1) DK1200095T3 (pl)
ES (1) ES2246874T3 (pl)
HK (1) HK1049116B (pl)
HU (1) HUP0202424A3 (pl)
IL (2) IL147604A0 (pl)
MX (1) MXPA02000411A (pl)
NO (1) NO329558B1 (pl)
NZ (1) NZ517130A (pl)
PL (1) PL198723B1 (pl)
RU (1) RU2268727C2 (pl)
SK (1) SK286020B6 (pl)
TR (1) TR200200053T2 (pl)
TW (1) TWI280880B (pl)
UA (1) UA73134C2 (pl)
WO (1) WO2001003699A1 (pl)
ZA (1) ZA200200265B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
AR039352A1 (es) * 2001-05-18 2005-02-16 Solvay Pharm Gmbh Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5.
CN100519561C (zh) * 2001-09-10 2009-07-29 泰博特克药品有限公司 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
IL162645A0 (en) 2002-01-16 2005-11-20 Solvay Pharm Bv solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
AR046454A1 (es) 2003-11-18 2005-12-07 Solvay Pharm Gmbh Uso de un compuesto de acido benzazepin-n-acetico, composicion farmaceutica, y procedimiento para la produccion de dicha composicion farmaceutica
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
CN101438155B (zh) * 2006-02-27 2013-04-24 靶向分子诊断有限责任公司 一种预测使用酪氨酸激酶抑制剂的处理的心脏毒性的方法
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US20070292503A1 (en) * 2006-06-16 2007-12-20 Gorissen Henricus R Oral pharmaceutical composition of poorly water-soluble active substance
US20070299054A1 (en) * 2006-06-22 2007-12-27 Rajesh Jain Oral pharmaceutical composition of a poorly water-soluble active agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
UA64690C2 (en) * 1993-07-21 2004-03-15 Yamanouty Farmaceutical Co Ltd A condensed benzadepine derivative, an intermediate compound for preparing thereof and a pharmaceutical composition
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
AU1146099A (en) * 1997-09-18 1999-04-05 Janssen Pharmaceutica N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceuticalagents
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen

Also Published As

Publication number Publication date
DK1200095T3 (da) 2005-11-14
ZA200200265B (en) 2003-03-26
CN1267099C (zh) 2006-08-02
HK1049116A1 (en) 2003-05-02
SK286020B6 (sk) 2008-01-07
AU782733B2 (en) 2005-08-25
HUP0202424A3 (en) 2003-03-28
CZ299070B6 (cs) 2008-04-16
CZ200252A3 (cs) 2002-08-14
NZ517130A (en) 2004-10-29
DE50011388D1 (de) 2006-03-02
KR20020019514A (ko) 2002-03-12
JP4824235B2 (ja) 2011-11-30
UA73134C2 (en) 2005-06-15
EP1200095A1 (de) 2002-05-02
RU2268727C2 (ru) 2006-01-27
NO329558B1 (no) 2010-11-15
WO2001003699A1 (de) 2001-01-18
NO20020132L (no) 2002-03-12
US6906059B2 (en) 2005-06-14
ES2246874T3 (es) 2006-03-01
AU6157200A (en) 2001-01-30
HUP0202424A2 (hu) 2002-11-28
BR0012442A (pt) 2002-04-02
EP1200095B1 (de) 2005-10-19
KR100738940B1 (ko) 2007-07-12
TWI280880B (en) 2007-05-11
CA2377904A1 (en) 2001-01-18
US20030040512A1 (en) 2003-02-27
CA2377904C (en) 2009-03-24
SK142002A3 (en) 2002-06-04
CN1373666A (zh) 2002-10-09
DE19932555A1 (de) 2001-01-18
HK1049116B (zh) 2006-12-08
NO20020132D0 (no) 2002-01-11
IL147604A (en) 2006-12-31
AR024476A1 (es) 2002-10-02
ATE306926T1 (de) 2005-11-15
MXPA02000411A (es) 2002-07-02
PL198723B1 (pl) 2008-07-31
TR200200053T2 (tr) 2002-05-21
IL147604A0 (en) 2002-08-14
JP2003504336A (ja) 2003-02-04

Similar Documents

Publication Publication Date Title
IL147604A0 (en) Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances
AU5259100A (en) Medicament
HUP0104901A3 (en) Medicament dispenser
IL148163A0 (en) Iv guard
HRP20020375A2 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
GB9924780D0 (en) Medicament dispenser
AU1961300A (en) Wall, preferably a protective wall
GB9930071D0 (en) Medicaments
ZA200201502B (en) Safety syringe.
AU4599500A (en) Safe
GB2354952B (en) The hay fever guard
GB9924990D0 (en) Medicaments
GB2370286B (en) Pesticide protective articles
EP1225939A4 (en) MEDICATION CARTRIDGE
GB9827865D0 (en) Medicament
GB9929040D0 (en) Medicaments
AU7655700A (en) Medicament combinations
GB9908432D0 (en) Veneers
GB9904935D0 (en) Medicaments
ZA200004224B (en) Protective shroud.
GB9929405D0 (en) Medicament
GB9911499D0 (en) Medicament
GB9921491D0 (en) Multiple hit detector
ZA200006899B (en) Protection arrangement.
ZA200002670B (en) Safe.

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120710